Resveratrol could bind to β1-integrin receptors, and further studies demonstrated that resveratrol inhibited the β1-integrin/HIF-1α signaling axis in the TME to overcome the drug resistance in CRC cells [123,130,137]. This evidence concerns the gene HIF1A and colorectal carcinoma.